Angewandte Chemie International Edition · 2018 · 56 citations · 21 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoveryLead OptimizationCombinatorial SynthesisHedgehog SignalingLigand-based DesignPotency OptimizationHedgehog Pathway InhibitorsHedgehog Signaling InhibitionKinase Inhibitor Library DesignKinase InhibitorsPharmacological Targeting Of Hedgehog SignalingPrivileged Scaffold IdentificationPrivileged Scaffold LibrariesSignal Transduction In Hedgehog Pathway
Reported is the identification of the furo[3,2-b]pyridine core as a novel scaffold for potent and highly selective inhibitors of cdc-like kinases (CLKs) and efficient modulators of the Hedgehog signaling pathway. Initially, a diverse target compound set was prepared by synthetic sequences based on chemoselective metal-mediated couplings, including assembly of the furo[3,2-b]pyridine scaffold by copper-mediated oxidative cyclization. Optimization of the subseries containing 3,5-disubstituted furo[3,2-b]pyridines afforded potent, cell-active, and highly selective inhibitors of CLKs. Profiling of the kinase-inactive subset of 3,5,7-trisubstituted furo[3,2-b]pyridines revealed sub-micromolar modulators of the Hedgehog pathway.
21
Comprehensive characterization of the Published Kinase Inhibitor Set
Jonathan M. Elkins, Vita Fedele, M. Szklarz et al. · Nature Biotechnology · 2015 · 350 citations
Dual kinase-bromodomain inhibitors for rationally designed polypharmacology
Pietro Ciceri, Susanne Müller, Alison O’Mahony et al. · Nature Chemical Biology · 2014 · 350 citations · Full text